Fate Therapeutics Inc. sell Bank of America Co.
Start price
28.03.24
/
50%
€6.80
Target price
28.03.25
€5.56
Performance (%)
-46.99%
Price
09.05.24
€3.61
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Fate Therapeutics Inc. is performing very well with a performance of -46.99%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fate Therapeutics Inc. | -5.579% | -5.579% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat